Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polyvinyl alcohol (PVA) is a synthetic polymer utilized in various medical applications. In interventional radiology, it is employed as an embolic agent, often in the form of microspheres, for procedures such as transarterial chemoembolization (TACE) of primary liver cancer and bariatric embolization of the left gastric artery for obesity. Its mechanism in these contexts involves the physical occlusion of blood vessels. Additionally, PVA is a common ingredient in artificial tear solutions for the treatment of dry eye conditions like keratoconjunctivitis sicca, where it functions to lubricate and protect the ocular surface.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyvinyl alcohol.